Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
about
Unraveling insulin-like growth factor binding protein-3 actions in human diseaseIGF-1, oxidative stress and atheroprotectionIncremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality predictionHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Mortality is associated with inflammation, anemia, specific diseases and treatments, and molecular markersA robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations.Insulin-like growth factor-I and cancer mortality in older men.Association between serum insulin-like growth factor I or IGF-binding protein 3 and estimated glomerular filtration rate: results of a population-based sample.A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly menLow circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.Aging, atherosclerosis, and IGF-1Comparative endocrinology of aging and longevity regulationDecline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study.Highlights From the Institute for Functional Medicine's 2014 Annual Conference: Functional Perspectives on Food and Nutrition: The Ultimate Upstream Medicine.Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment.Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future ResearchGenomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits.Differential morphology and homogeneity of tissue-engineered cartilage in hydrodynamic cultivation with transient exposure to insulin-like growth factor-1 and transforming growth factor-β1IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a Black population: A five-year prospective study.Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells.Association study of IGFBP1 and IGFBP3 polymorphisms with hypertension and cardio-cerebral vascular diseases in a Chinese Han population.Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP).IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study.Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.The concept of multiple hormonal dysregulation.Cohort Profile: The Study of Health in PomeraniaIdentification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients
P2860
Q24650060-1127E750-DB55-4291-899F-759171E15DD9Q27694593-562340BC-539E-4FD9-BD9E-502AA8526C08Q28731264-36A71DFE-87FA-4458-A74E-C7FC51395CC9Q33569163-9A094171-AC8C-4A22-ADF8-73DF5E0FC10DQ33579874-56E1837F-C847-41BE-BD66-26BFC3D5EAECQ33725695-094DE859-7A47-4181-8B50-A96DCA15062AQ33738660-491D7626-C2A5-4339-A014-F0EECF76503AQ34511641-5CF70ED6-4986-4F4C-A008-CA24D1AC9836Q34597879-DA54187A-016D-4ED4-ACE6-B04E4DAD9907Q34647846-A2C2A790-E53B-471F-88B0-068259DDDEBAQ34979827-E9A32C1D-E4C3-4169-A56E-19E5FE237174Q35193839-63ED3240-BCC7-4E38-B810-2EBC009DF488Q35947440-3FFBF1C6-39C9-4EB0-8587-4D4409FDE013Q35971938-8EA75C52-90DF-44F8-9A3F-1E253F90076CQ36069900-2DC2A1FB-F4DF-410E-B9AB-DD595C03F327Q36384378-A3F55F34-D3AE-4D1B-B04A-E977C274543EQ36622917-0BD12BA9-B6CC-47E0-8655-D8AC5587F222Q36984213-1FCF091D-3868-42E6-8EA7-A1C6E37AD1FFQ37035744-17FC0AC7-0943-46D1-9442-6EDFADA8266AQ37235560-13A3C528-7F56-496B-B9FB-536D6E83657FQ37253773-5A95682C-BC96-449A-9922-CA585B1666B5Q37829755-E4355664-0C14-4E06-8DDE-AEC2DB5A9F4FQ40133659-CF405869-3770-49B4-8938-C0939C1A2132Q40392354-54B68A7A-67BD-463C-894E-09CFBF7A5BBDQ43192139-76CF3EE0-2BA2-467B-97C2-705DA1E47F3CQ43235442-A1B7646B-1454-4866-80DB-2862F0D66B33Q43815914-D8B4413B-2F45-4A09-919E-4B195DFD288BQ45388117-7141D20B-094B-41C5-951A-B0059943C6D7Q46857844-005BF011-1979-4C52-BC2F-13A793D084BFQ54867290-8888549C-3CF5-4204-B445-C9F83BF93309Q57429582-4D89743C-0D15-4684-B7A9-7D43D8B92BCCQ58946262-CA451996-0B9D-4A87-938C-50DB93EA44BA
P2860
Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Mortality and serum insulin-li ...... ding protein 3 concentrations.
@en
Mortality and serum insulin-like growth factor
@nl
type
label
Mortality and serum insulin-li ...... ding protein 3 concentrations.
@en
Mortality and serum insulin-like growth factor
@nl
prefLabel
Mortality and serum insulin-li ...... ding protein 3 concentrations.
@en
Mortality and serum insulin-like growth factor
@nl
P2093
P356
P1476
Mortality and serum insulin-li ...... nding protein 3 concentrations
@en
P2093
Dieter Rosskopf
Elisabeth Spilcke-Liss
Georg Brabant
Henri Wallaschofski
Henry Völzke
Jan Lüdemann
Matthias Nauck
Nele Friedrich
Stephan B Felix
P304
P356
10.1210/JC.2008-2138
P407
P577
2009-02-17T00:00:00Z